The objective of this document is to provide recommendations for the genetic counseling of
patients and families undergoing evaluation for neurofibromatosis type 1 (NF1) or who have …

Health care transition, or HCT, is the process of adolescents and young adults moving from
a child/family-centered model of health care to an adult/patient-centered model of health care…

Neurofibromatosis type 1 (NF1) clinical care is on the cusp of a transformative shift. With the
success of recent clinical trials using MEK inhibitors, an increasing number of NF1 patients …

The goal of this practice resource is to provide genetic counselors and other healthcare
professionals with a resource to reference when providing genetic counseling services to …

Purpose The coronavirus disease 2019 (COVID-19) pandemic has had unprecedented
impact on the provision of medical care for genetic disorders. The purpose of this study was to …

Purpose: “Jaffe–Campanacci syndrome” describes the complex of multiple nonossifying
fibromas of the long bones, mandibular giant cell lesions, and café-au-lait macules in …

Background Our primary aim was to assess the ability of a non-profit foundation-sponsored
clinic network to facilitate access to specialized care for patients with neurofibromatoses (NF)…

Neurofibromatosis 1 (NF1) is a common genetic disorder typically diagnosed in childhood
and characterized by cutaneous findings, nerve sheath tumors, skeletal abnormalities, …

Neurofibromatosis (NF) and schwannomatosis (SWN) are genetic conditions characterized
by the risk of developing nervous system tumors. Recently revised diagnostic criteria include …

Neurofibromatosis type 1 (NF1) conveys significant disease morbidity and lower quality of
life compared to the general population. Research has shown that decreased positive health …